iShares Neuroscience and Healthcare ETF Rating $27.54 -0.82 (-2.89%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.81Holdings in IBRN have an aggregate rating of Moderate Buy based on 305 analyst ratings issued in the past year covering 19 companies (61.9% of the portfolio).IBRN Aggregate Price Target$27.54High Prediction$27.54Average Prediction$27.54Low Prediction$27.54Holdings in IBRN have an aggregate price target of $27.54 and a range of $27.54 to $27.54 covering 19 companies (61.9% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.54%SRRKScholar Rock$39.46-3.7%4.5261 of 5 stars3.07$47.00 19.1%15Analyst ForecastInsider Trade4.15%PTCTPTC Therapeutics$66.23+0.3%3.335 of 5 stars2.53$69.00 4.2%15Analyst ForecastInsider Trade3.96%BIIBBiogen$146.57-2.0%4.6184 of 5 stars2.32$180.15 22.9%31Trending NewsAnalyst ForecastAnalyst Revision3.93%ARGXargenex$796.92-1.0%3.6703 of 5 stars3.00$813.32 2.1%24Analyst Forecast3.88%ALKSAlkermes$31.21-0.5%4.3472 of 5 stars2.93$42.00 34.6%143.85%SUPNSupernus Pharmaceuticals$49.00-1.0%4.0243 of 5 stars3.00$64.00 30.6%5Trending NewsAnalyst Forecast3.69%XENEXenon Pharmaceuticals$39.64-4.0%2.6211 of 5 stars2.92$53.67 35.4%12Positive NewsAnalyst ForecastAnalyst Revision3.63%CPRXCatalyst Pharmaceuticals$20.36-2.2%4.7794 of 5 stars3.00$33.20 63.1%9Analyst ForecastBuyback Announcement3.56%NBIXNeurocrine Biosciences$136.63-1.3%4.7825 of 5 stars2.80$163.44 19.6%20Positive NewsAnalyst Forecast3.50%AXSMAxsome Therapeutics$121.71-0.7%4.6756 of 5 stars3.00$177.93 46.2%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.47%SRPTSarepta Therapeutics$22.11-4.4%4.5295 of 5 stars2.03$34.42 55.7%29Analyst Forecast3.17%DNLIDenali Therapeutics$15.37-4.9%4.2296 of 5 stars3.06$33.50 118.0%17Analyst Forecast3.11%ACADACADIA Pharmaceuticals$20.06-2.8%4.5018 of 5 stars2.65$29.12 45.2%20Analyst Revision3.03%CNTACentessa Pharmaceuticals$22.31-2.3%2.9462 of 5 stars2.91$32.38 45.1%11Analyst Forecast2.56%DYNDyne Therapeutics$14.05-4.3%3.2639 of 5 stars2.88$34.07 142.5%17News CoverageAnalyst Forecast2.24%BHVNBiohaven$15.89-7.8%2.7644 of 5 stars3.00$48.85 207.4%16Analyst Forecast2.02%AVDLAvadel Pharmaceuticals$14.00-1.4%2.8211 of 5 stars2.70$20.86 49.0%10Trending NewsAnalyst DowngradeAnalyst Revision1.84%EWTXEdgewise Therapeutics$15.11-5.9%2.4602 of 5 stars2.69$38.83 157.0%13News CoverageAnalyst Forecast1.78%TSHATaysha Gene Therapies$4.88-2.4%2.3621 of 5 stars2.80$9.00 84.4%10Analyst ForecastGap Up This page (NYSEARCA:IBRN) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
